What changed in the March 12, 2026 UBS note on LEVI analyst rating?

UBS **maintained** its **Buy** on March 12, 2026 at 10:42 AM and did not issue a new price target. The note reaffirmed UBS’s positive view after investor presentations and produced a small market move of **0.11% ($0.02)**.

Does the UBS maintained Buy mean investors should buy LEVI now?

A maintained **Buy** is a favorable signal but not a guarantee. It indicates UBS expects outperformance. Investors should weigh valuation, risk tolerance, and upcoming sales and margin data before buying LEVI.

How does the Meyka Grade affect the LEVI analyst rating view?

Meyka AI rates LEVI with a grade of **B+**, reflecting S&P 500 comparison, sector performance, financial growth, key metrics, and analyst consensus. The grade is an additional analytical lens, not investment advice.

Were any price targets released with the UBS note on LEVI?

No. UBS reiterated the **Buy** rating without publishing a new LEVI price target in the March 12, 2026 note. Investors should consult prior UBS targets and the broader analyst consensus for valuation context.

Analyst Ratings

UBS Maintains Buy on Levi Strauss & Co. (LEVI) March 2026

ByHuzaifa Zahoor March 13, 2026March 13, 2026

UBS on March 12, 2026 at 10:42 AM maintained a Buy rating on Levi Strauss & Co. (LEVI). The LEVI analyst rating remains Buy, and the note produced a modest stock move of 0.11% ($0.02). UBS reiterated its view after recent company presentation activity, leaving guidance and price targets unchanged in the published note. Meyka AI rates LEVI with a grade of B+ and monitors this coverage alongside macro and sector signals.